Trial Profile
A Double-Blind Crossover Study In Healthy Volunteers to Compare Two Formulations of Androxal
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Enclomifene (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- Sponsors Repros Therapeutics
- 23 Jan 2014 According to ClinicalTrials.gov record, status changed from active, not recruiting to completed.
- 21 Nov 2013 New trial record